BiotechTube
Alturas Analytics

Alturas Analytics

Moscow, United States· Est.
alturasanalytics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Founded in 2000 and headquartered in Moscow, Idaho, Alturas Analytics is a privately held, revenue-generating bioanalytical CRO providing essential laboratory services to the pharmaceutical and biotechnology industries. The company operates a 30,000-square-foot, purpose-built facility and leverages its deep expertise in LC-MS/MS and GC-MS/MS to offer method development, validation, and pharmacokinetic/toxicokinetic (PK/TK) analysis under GLP standards. With a strong focus on data integrity, quality assurance, and client collaboration, Alturas positions itself as a specialized partner for complex bioanalytical challenges, particularly in supporting drug development from research through regulatory submission.

Diagnostics

Technology Platform

Specialized expertise in Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) and Gas Chromatography-Tandem Mass Spectrometry (GC-MS/MS) for quantitative bioanalysis of drugs, metabolites, and biomarkers in biological samples. The platform includes method development/validation, GLP-compliant operations, and a strong IT/data management infrastructure.

Opportunities

Growth is driven by increasing outsourcing in pharma R&D and the rising complexity of novel drug modalities (e.g., ADCs, peptides) that require sophisticated LC-MS/MS analysis.
Expansion of services into adjacent areas like biomarker quantification and leveraging its research reputation to secure high-value, late-stage regulatory projects present further avenues for growth.

Risk Factors

Revenue is tied to cyclical pharmaceutical R&D spending and client concentration.
The company faces intense competition from both large full-service CROs and niche players.
Regulatory compliance failures or failure to adopt new analytical technologies could damage its reputation and core business model.

Competitive Landscape

Alturas competes in the specialized bioanalytical CRO segment against other focused LC-MS/MS labs (e.g., Q2 Solutions' bioanalytical division, Frontage Labs, Celerion) and the bioanalytical departments of large, full-service CROs (IQVIA, Labcorp, PPD). Its differentiation lies in its deep technical expertise, client-collaborative model, and focus on complex, regulatory-driven projects within its technological niche.

More companies in Diagnostics & Precision Medicine →More companies in United States →